Kidney transplantation in HIV-positive adults: The UK experience

International Journal of STD and AIDS

Volumn 25, Issue 1, 2014, Pages 57-66

  Gathogo, Esther N ^a,b,h   Hamzah, Lisa ^a,c,h   Hilton, Rachel ^d,h   Marshall, Neal ^b,h   Ashley, Caroline ^b   Harber, Mark ^b,h   Levy, Jeremy B ^e,h   Jones, Rachael ^f,h   Boffito, Marta ^f,h   Khoo, Saye H ^g,h   Drage, Martin ^d,h   Bhagani, Sanjay ^b,h   Post, Frank A ^a,c,h  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^c KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^d GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^e IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^f CHELSEA AND WESTMINSTER HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^g UNIVERSITY OF LIVERPOOL   (United Kingdom)

^h UK HIV Kidney Transplantation Study Group   (United Kingdom)

Author keywords

AIDS; antiretroviral therapy; calcineurin inhibitor; dialysis; end stage kidney disease; HIV; HIV associated nephropathy; HIVAN; kidney; renal failure; transplantation

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CORTICOSTEROID; DACLIZUMAB; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY; VALGANCICLOVIR; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE GRAFT REJECTION; ADULT; ARTICLE; ATYPICAL MYCOBACTERIOSIS; BK VIRUS; CANDIDIASIS; CD4 LYMPHOCYTE COUNT; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; COHORT ANALYSIS; DELAYED GRAFT FUNCTION; DISEASE COURSE; END STAGE RENAL DISEASE; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HEART FAILURE; HEPATITIS B; HEPATITIS C; HETEROSEXUALITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED NEPHROPATHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; KAPOSI SARCOMA; KIDNEY ALLOGRAFT; KIDNEY DONOR; KIDNEY TRANSPLANTATION; LACTIC ACIDOSIS; LIVING DONOR; MALE; MEN WHO HAVE SEX WITH MEN; MIDDLE AGED; MIXED INFECTION; PLASMAPHERESIS; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; UNITED KINGDOM; VIREMIA; VIRUS HEPATITIS; VIRUS LOAD;

AIDS; ANTIRETROVIRAL THERAPY; CALCINEURIN INHIBITOR; DIALYSIS; END STAGE KIDNEY DISEASE; HIV; HIV-ASSOCIATED NEPHROPATHY; HIVAN; KIDNEY; RENAL FAILURE; TRANSPLANTATION;

ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; GREAT BRITAIN; HIV INFECTIONS; HUMANS; IMMUNOSUPPRESSION; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84890688531     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1177/0956462413493266     Document Type: Article

References (30)

1. UNAIDS Report on the Global AIDS Epidemic 2012, http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/gr2012/20121120_UNAIDS_Global_Report_2012_en.pdf (accessed 2 April 2013).
2. Health Protection Agency. HIV in the United Kingdom: 2012 Report. London: Health Protection Services, Colindale, November 2012, http://www.hpa.org.uk/Publications/InfectiousDiseases/HIVAndSTIs/1211HIVintheUK2012/ (accessed 5 April 2013).
3. Ibrahim F,Hamzah L,Jones R, et al.Baseline kidney function as predictor of mortality and kidney disease progression in HIV-positive patients.Am J Kidney Dis. 2012;60:539-547.
4. Bansi L,Hughes A,Bhagani S, et al.Clinical epidemiology of HIV-associated end-stage renal failure in the UK.AIDS. 2009;23:2517-2521.
5. Post FA,Campbell LJ,Hamzah L, et al.Predictors of renal outcome in HIV-associated nephropathy.Clin Infect Dis. 2008;46:1282-1289.
6. Lucas GM,Eustace JA,Sozio S, et al.Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study.AIDS. 2004;18:541-546.
7. Szczech LA,Gupta SK,Habash R, et al.The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection.Kidney Int. 2004;66:1145-1152.
8. Podlekareva D,Mocroft A,Dragsted UB, et al.Factors associated with the development of opportunistic infections in HIV-1-infected adults with high CD4+ cell counts: a EuroSIDA study.J Infect Dis. 2006;194:633-641.
9. van Sighem AI,Gras LA,Reiss P, et al.Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals.AIDS. 2010;24:1527-1535.
10. Trullas JC,Cofan F,Tuset M, et al.Renal transplantation in HIV-infected patients: 2010 update.Kidney Int. 2011;79:825-842.
11. Swanson SJ,Kirk AD,Ko CW, et al.Impact of HIV seropositivity on graft and patient survival after cadaveric renal transplantation in the United States in the pre highly active antiretroviral therapy (HAART) era: an historical cohort analysis of the United States Renal Data System.Transpl Infect Dis. 2002;4:144-147.
12. Kumar MS,Sierka DR,Damask AM, et al.Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive patients.Kidney Int. 2005;67:1622-1629.
13. Touzot M,Pillebout E,Matignon M, et al.Renal transplantation in HIV-infected patients: the Paris experience.Am J Transplant. 2010;10:2263-2269.
14. Roland ME,Barin B,Carlson L, et al.HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes.Am J Transplant. 2008;8:355-365.
15. Stock PG,Barin B,Murphy B, et al.Outcomes of Kidney Transplantation in HIV-Infected Recipients.N Engl J Med. 2010;363:2004-2014.
16. Bickel M,Anadol E,Vogel M, et al.Daily dosing of tacrolimus in patients treated with HIV-1 therapy containing a ritonavir-boosted protease inhibitor or raltegravir.J Antimicrob Chemother. 2010;65:999-1004.
17. Pulzer A,Seybold U,Schönermarck U, et al.Calcineurin inhibitor dose-finding before kidney transplantation in HIV patients.Transpl Int. 2013;26:254-258.
18. Ibrahim F,Hamzah L,Jones R, et al.Comparison of CKD-EPI and MDRD to estimate baseline renal function in HIV-positive patients.Nephrol Dial Transplant. 2012;27:2291-2297.
19. NHS Blood and Transplant: Transplant Activity in the UK. Activity Report 2010/11, http://www.organdonation.nhs.uk:8001/ukt/statistics/transplant_activity_report/archive_activity_reports/pdf/ukt/activity_report_2010_11.pdf (accessed 30 November 2012).
20. NHS National Institute for Clinical Excellence (NICE): Immunosuppressive therapy for renal transplantation in adults. London: National Institute for Clinical Excellence. Technology Appraisal 85, September 2004, http://www.nice.org.uk/nicemedia/live/11544/32940/32940.pdf (accessed 30 November 2012).
21. Neuhaus J,Jacobs DR,Baker JV, et al.Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection.J Infect Dis. 2010;201:1788-1795.
22. Hunt PW,Martin JN,Sinclair E, et al.T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy.J Infect Dis. 2003;187:1534-1543.
23. Douek DC,Roederer M,Koup RA.Emerging concepts in the immunopathogenesis of AIDS.Annu Rev Med. 2009;60:471-484.
24. Nankivell BJ,Alexander SI.Rejection of the kidney allograft.N Engl J Med. 2010;363:1451-1462.
25. Malat GE,Ranganna KM,Sikalas N, et al.High frequency of rejections in HIV-positive recipients of kidney transplantation: a single center prospective trial.Transplantation. 2012;94:1020-1024.
26. Mazuecos A,Fernandez A,Andres A, et al.HIV infection and renal transplantation.Nephrol Dial Transplant. 2011;26:1401-1407.
27. Liverpool HIV Pharmacology Group, the University of Liverpool, www.hiv-druginteractions.org (accessed 30 November 2012).
28. Gathogo E, Hamzah L, Campbell L,et al.The United Kingdom experience of kidney transplantation in HIV-positive patients. In: 6th International AIDS Society conference on HIV pathogenesis, treatment and prevention, Rome, Italy, 2011. Available at: http://pag.ias2011.org/Abstracts.aspx?AID=1524.
29. Bhagani S,Sweny P,Brook G.Guidelines for kidney transplantation in patients with HIV disease.HIV Med. 2006;7:133-139.
30. Tricot L,Teicher E,Peytavin G, et al.Safety and efficacy of raltegravir in HIV-infected transplant patients cotreated with immunosuppressive drugs.Am J Transplant. 2009;9:1946-1952.